ERBB2 and breast cancer: We further validated the DEG36 and SigDEG23 using the TCGA PanCancer Atlas BC cohort, another large BC dataset that contains luminal (n = 689), basal-like (n = 169), normal-like (n = 35), and HER2+ (HER2-enriched, n = 75) BCs, respectively.